Inhibition of Helicobacter pylori-induced cyclo-oxygenase-2 aggravates NSAID-caused gastric damage in Mongolian gerbils

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 4, 2002, Pages 847-855

  Futagami, S ^a   Hiratsuka, T ^a   Wada, K ^a   Tatsuguchi, A ^a   Tsukui, T ^a   Miyake, K ^a   Akamatsu, T ^a   Hosone, M ^a   Sakamoto, C ^a   Kobayashi, M ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; MYELOPEROXIDASE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; GERBIL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH INJURY; STOMACH MUCOSA; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; GASTRIC MUCOSA; GERBILLINAE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; INDOMETHACIN; ISOENZYMES; MALE; PEPTIC ULCER HEMORRHAGE; PEROXIDASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STOMACH ULCER;

EID: 0036109165     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01211.x     Document Type: Article

References (35)

1. Helicobacter pylori in peptic ulcer disease
2. Risk for serious gastrointestinal complications related to use of non steroidal anti-inflammatory drugs. A meta-analysis
3. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines
4. Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo
5. Characterization of prostaglandin G/H synthase I and 2 in rat, dog, monkey, and human gastrointestinal tracts
6. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
7. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pglori gastritis
8. Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans
9. 2 synthesis in MKN 28 gastric mucosal cells in vitro
10. Long-term follow-up of Helicobacter pylori treatment in non-ulcer dyspepsia patients
11. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers
12. Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAD therapy
13. Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injuries: The role of Helicobacter pylori
14. Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: A controlled double-blind trial
15. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro
16. The potentiating actions of cigarette smoking on ethanol-induced gastric mucosal damage in rats
17. A novel antiulcerogenic stable radical prevents gastric lesions in rats
18. Do sensory neurons mediate adaptive cytoprotection of gastric mucosa against bile acid injury?
19. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models
20. Anti-ulcerogenic properties of endothelin receptor antagonists in the rat
21. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice
22. Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation
23. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic
24. Pharmacological analysis of cyclooxygenase-1 in inflammation
25. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
26. Selectivity of nonsteroidal antiinfiammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
27. A single amino acid difference between cyclooxygenase-1 (COX-l) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors
28. Long-term nonsteroidal anti-inflammatory drug use and Helicobacter pylori infection
29. Omeprazole compared with misoprostole for ulcers associated with nonsteroidal antiinflammatory drugs
30. Is Helicobacter pylori infection a risk or protective factor for mucosal lesion development in patients chronically treated with acetylsalicylic acid?
31. Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori
32. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: Implications for gastrointestinal toxicity
33. Gastric ulceration induced by non-steroidal anti-inflammatory drugs in a neutrophil dependent process
34. Inducible cyclooxygenase may have anti-inflammatory properties
35. NSAID-induced gastric damage in rats: Requirement for inhibition of both cyclooxygenase I and 2